Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/144.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor > Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a receptor integral to or derived from a lymphocytic or a lymphocytic-like cell.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13

Patent Number Title Of Patent Date Issued
7959917 Binding members for IgE molecules Jun. 14, 2011
7959918 Methods for treating vascular disease Jun. 14, 2011
7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases Jun. 7, 2011
7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation May. 31, 2011
7947272 Compositions and methods of tolerizing a primate to an antigen May. 24, 2011
7947496 Cytotoxicity mediation of cells evidencing surface expression of CD44 May. 24, 2011
7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies May. 10, 2011
7939076 Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist May. 10, 2011
7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof Apr. 26, 2011
7927592 Method of inhibiting complement activation Apr. 19, 2011
7927595 Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies Apr. 19, 2011
7927596 Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides Apr. 19, 2011
7923011 Antibodies to lymphotoxin-alpha Apr. 12, 2011
7919089 Pharmaceutical composition comprising a bispecific antibody for EpCAM Apr. 5, 2011
7914784 Anti-IGF-IR antibodies and uses thereof Mar. 29, 2011
7914789 HEMCM42 antibodies Mar. 29, 2011
7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof Mar. 22, 2011
7910099 Antibodies to VLA-1 Mar. 22, 2011
7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies Mar. 22, 2011
7910104 Modified anti-CD52 antibody Mar. 22, 2011
7910708 Anti-IL13 human antibodies Mar. 22, 2011
7901680 Dock-and-lock (DNL) vaccines for cancer therapy Mar. 8, 2011
7901678 Medicinal compositions containing Fc receptor .gamma. chain activator Mar. 8, 2011
7897149 Fully human anti-VAP-1 monoclonal antibodies Mar. 1, 2011
7897151 Anti-IgE vaccines Mar. 1, 2011
7892538 Monovalent ligand of the Fc.alpha.RI receptor as an anti-inflammatory agent Feb. 22, 2011
7892546 Anti-CXCR4 antibodies Feb. 22, 2011
7892551 Antibody kit for enumeration of CD4+ lymphocytes Feb. 22, 2011
7883703 Methods of modulating immunity Feb. 8, 2011
7867475 Immune regulation based on the depletion of CD69+ cells Jan. 11, 2011
7862818 Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10 Jan. 4, 2011
7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies Nov. 23, 2010
7833529 Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor Nov. 16, 2010
7833530 Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies Nov. 16, 2010
7829092 Recombinant anti-VLA4 antibody molecules Nov. 9, 2010
7829096 CD40L-specific monovalent polypeptides Nov. 9, 2010
7824683 Methods for augmenting an immune response using anti-CD40 antibodies Nov. 2, 2010
7825224 Product and method for treatment of conditions associated with receptor-desensitization Nov. 2, 2010
7820161 Treatment of autoimmune diseases Oct. 26, 2010
7820166 Potent T cell modulating molecules Oct. 26, 2010
7820170 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies Oct. 26, 2010
7815908 Methods and compositions for treating and preventing disease associated with .alpha.V.beta.5 integrin Oct. 19, 2010
7807167 Administration of agents for the treatment of inflammation Oct. 5, 2010
7803376 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Sep. 28, 2010
7790166 Anti-CD40 antibodies capable of blocking B-cell activation Sep. 7, 2010
7790405 Solution phase biopanning method using engineered decoy proteins Sep. 7, 2010
7744888 Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies Jun. 29, 2010
7744884 Neutralizing antibodies and methods of use thereof Jun. 29, 2010
7744881 Human DR4 antibodies and uses thereof Jun. 29, 2010
7744877 Expression and use of anti-CD20 Antibodies Jun. 29, 2010

1 2 3 4 5 6 7 8 9 10 11 12 13










 
 
  Recently Added Patents
Dual-box location aware and dual-bitmap voltage domain aware on-chip variation techniques
Escutcheon
High-density fiber optic modules and module housings and related equipment
Perception-based artifact quantification for volume rendering
Mass spectrometry method
Video stabilization
Lighting apparatus
  Randomly Featured Patents
Polyamide resin-protide conjugate, preparation and uses
Combination white light and colored LED light device with active ingredient emission
Electroless plating system
Receptacle for radioactive material
Drum funnel
Method and apparatus for determining individual or common mobile subscriber number in mobile network for handling multiple subscribers having the same calling line identity
Low ratio RTV compositions and methods for making same
Package employing unique seal
Elastomer composition
Pultrusion method of making composite friction units